# AtlasXomics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/atlasxomics

- Industry: Biotechnology
- Headquarters: New Haven, US
- Website: www.atlasxomics.com
- Total disclosed funding: $3.9M
- Latest round: Series A (Dec 22, 2021)
- Investors on record: 1

## About

Based in Connecticut, US, and founded in 2020 by Rong Fan, AtlasXomics Inc. is a Yale spin-out and operates as a comprehensive spatial epigenome solution that gives researchers unprecedented insight into genomics, transcriptomics, and proteomics landscapes. In December 2021, AtlasXomics Inc. raised USD 3.9 million in series A funding led by new investor Spring Mountain Capital. As of July 2022, the company is led by its CEO Kenneth Wang. 

AtlasXomics Inc. offers Deterministic Barcoding in Tissue for spatial omics sequencing
(DBiT-seq) platform that provides clinicians and researchers with unprecedented multi-omics tissue atlases that leverages microfluidics and next-generation sequencing (NGS) to create transformative multi-omic maps (proteomics, transcriptomics, and epigenomics)
of tissue at cellular resolution. The company provides a detailed data report that consists of sample optimization, clustering, browser tracks, a detailed summary, gene accessibility maps, and motif analysis for the investigator to use in research.

## Funding rounds

- Series A, Dec 22, 2021, $3.9M — Spring Mountain Capital

## Investors

- Spring Mountain Capital (https://capitalatlas.ai/funds/spring-mountain-capital) — Series A